Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
vTv Therapeutics Inc. (VTVT) had Return on Tangible Equity of -69.88% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.09M |
|
-- |
|
-- |
|
$6.50M |
|
$-6.50M |
|
$0.29M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.50M |
|
$-6.49M |
|
6.58M |
|
6.58M |
|
$-0.77 |
|
$-0.77 |
|
| Balance Sheet Financials | |
$31.92M |
|
$0.02M |
|
$0.11M |
|
$32.03M |
|
$4.32M |
|
-- |
|
$18.81M |
|
$23.13M |
|
$8.90M |
|
$8.90M |
|
$8.90M |
|
3.19M |
|
| Cash Flow Statement Financials | |
$-5.69M |
|
-- |
|
-- |
|
$36.75M |
|
$31.06M |
|
$-5.69M |
|
$0.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.88% |
|
|
Return on Tangible Equity |
-69.88% |
-19.41% |
|
-69.88% |
|
$2.79 |
|
$-0.86 |
|
$-0.86 |
|